Multimodal Monitoring Study in Neuro Critical Care

Recruiting Observational Study
Subarachnoidal Hemorrhage Intacranial Hypertension Acute Trauma Brain Injury
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
During the first week after an acute cerebral injury, neurologic clinical exam is often irrelevant, limited by sedation use or spontaneous consciousness disorders. Hence, neurological monitoring of brain oxygen consumption, metabolic disorders, electrical activity is used to follow and prevent delayed cerebral injuries. Among those instruments, numerous are often described: intra cranial pressure…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * \- Patients hospitalized in neurologic critical care in Wertheimer Hospital, Bron * Monitored with the CNS MOBERG® monitoring system Exclusion Criteria: * \- Refusal to participate * Patients under legal protection
Contacts

Dr Baptiste Balança

04 72 35 75 76

baptiste.balanca@chu-lyon.fr

CONTACT